Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen in Mild COVID-19
NCT04433013Phase 3Withdrawn
- Sponsor
- Nanyang Technological University
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- HM (Herbal Medicine)
01
Overview
A Phase 3 trial of Lianhua Qingwen in coronavirus disease 2019 (COVID-19), sponsored by Nanyang Technological University. Planned start Jul 2020; status: withdrawn.
02
Drugs
Lianhua Qingwen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04433013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433013.